
Neurogene Inc.
USD36.68
-0.66 (-1.77%)
CEO
Rachel L. McMinn
IPO Date
2014-03-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$36.99
Prev. Close
$37.34
Day Low
$35.95
Day High
$37.37
52W Low
$15.93
52W High
$43.66
Market Cap
$0.58B
Volume
0.22M
| 13 Nov 2025 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 31 Oct 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 9 Oct 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 12 Jun 2025 | BMO Capital | Outperform | Outperform | maintain |
| 20 May 2025 | BMO Capital | Outperform | Outperform | maintain |
| 16 May 2025 | Baird | Outperform | Neutral | downgrade |
| 13 May 2025 | HC Wainwright & Co. | Buy | Buy | maintain |